Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

3.980 +0.030 (+0.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
29 30 Next >
Largest Psychedelic Compound-Based Drug Stocks On A Roll - Up 50% Since End Of June
The Psychedelic Compounds-Based Drug Stocks Index went up 9.8% this week and is now up 49.5% since the end of June albeit down 32.6% YTD. 
Via Talk Markets
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 3.61% at $1.00 LOSERS: 
Via Benzinga
Seelos Therapeutics, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 17.87% at $1.22 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 23, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24 
Via Benzinga
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 10.34% at $0.16 
Via Benzinga
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 29.35% at $0.14 LOSERS: 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 17, 2022
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 16, 2022
  
Via Benzinga
These Depression Players Are Top Picks For $400B Mental Healthcare Market, Says Analyst
HC Wainwright expects COMPASS Pathways Plc (NASDAQ: CMPS) and Cybin Inc (NYSE: CYBN) to be leaders in the emerging $400 billion mental healthcare market. 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
  
Via Benzinga
Major Psychedelic Stocks Down This Week; Still Up Since End Of June
The 8 stocks in our Psychedelic Compounds-Based Drug Stocks Index dropped 8.4% this week for the first time in 5 weeks but are still up 45.3% since then. 
Via Talk Markets
Mind Medicine, Numinus Wellness Among Top Psychedelic Movers From Today
  
Via Benzinga
Compass Pathways, Revive Therapeutics Among Top Psychedelic Movers Of Today
  
Via Benzinga
Psychedelic Stock Gainers And Losers From August 10, 2022
  
Via Benzinga
3 Best Psychedelic Stocks to Buy Now
These are three of the best psychedelic stocks to buy to get in on the next generation of treatment for mental health disorders. 
Via InvestorPlace
Cybin, Field Trip Health Among Top Psychedelic Movers Of Today
  
Via Benzinga
Compass Pathways to Begin New Phase 2 Psychedelic Trial for Anorexia
Via Investor Brand Network
BREAKING: COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secrets
Terran Biosciences Inc. is suing COMPASS Pathways (NASDAQ: CMPS) for the appropriation of trade secrets.    
Via Benzinga
GH Research, Numinus Wellness Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 29.83% at $15.80 
Via Benzinga
Psychedelic Stock Gainers And Losers From August 4, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 10.64% at $12.17 
Via Benzinga
Compass Pathways Reports Q2 Financial Results, R&D Expenses Keep Growing
COMPASS Pathways plc (NASDAQ: CMPS) released financial results for the second quarter 2022 and gave an update on recent progress across its business. Q2 2022 Financial Highlights 
Via Benzinga
ATAI Life Sciences, Allied Among Top Psychedelic Movers Of Today
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 7.61% at $3.82 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 4.95% at $0.34 
Via Benzinga
July Update: Psychedelic Compounds-Based Drug Stocks Index Up 23%; Remains Down 44% YTD
Of the 107 clinical-stage psychedelic drug stocks trading on North American stock exchanges only 8 have market caps of $50M or more, and trade for US$0.50/share or more. 
Via Talk Markets
Psychedelic Stock Gainers And Losers From July 29, 2022
GAINERS: Numinus Wellness (OTC:NUMIF) shares closed up 11.30% at $0.22 
Via Benzinga
Allied, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 19.46% at $0.55 
Via Benzinga
Psilocybin For Anorexia: Learn About Compass' Novel Phase 2 Trial Using Magic Mushroom's Main Compound
Psychedelics mental healthcare company Compass Pathways PLC. (NASDAQ: CMPS) has launched a phase 2 clinical study testing the efficacy of psilocybin with psychological support in people with anorexia... 
Via Benzinga
Allied, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 5.66% at $16.06 
Via Benzinga
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders
Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam... 
Via FinancialNewsMedia
Topics Law Enforcement
Exposures Legal
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.